{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:10:52Z","timestamp":1772719852748,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T00:00:00Z","timestamp":1243382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s12640-009-9061-x","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T17:09:25Z","timestamp":1248109765000},"page":"127-139","source":"Crossref","is-referenced-by-count":82,"title":["Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Nicoletta","family":"Schintu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Frau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Ibba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Garau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezio","family":"Carboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna R.","family":"Carta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,27]]},"reference":[{"key":"9061_CR1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1471-4159.2008.05651.x","volume":"107","author":"D Alvarez-Fischer","year":"2008","unstructured":"Alvarez-Fischer D, Guerreiro S, Hunot S, Saurini F, Marien M, Sokoloff P, Hirsch EC, Hartmann A, Michel PP (2008) Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid. J Neurochem 107:701\u2013711","journal-title":"J Neurochem"},{"key":"9061_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/neur.1996.0018","volume":"5","author":"P Anglade","year":"1996","unstructured":"Anglade P, Mouatt-Prigent A, Agid Y, Hirsch E (1996) Synaptic plasticity in the caudate nucleus of patients with Parkinson\u2019s disease. Neurodegeneration 5:121\u2013128","journal-title":"Neurodegeneration"},{"key":"9061_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-0987(00)00170-6","volume":"12","author":"T Araki","year":"2001","unstructured":"Araki T, Mikami T, Tanji H, Matsubara M, Imai Y, Mizugaki M, Itoyama Y (2001) Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse. Eur J Pharm Sci 12:231\u2013238","journal-title":"Eur J Pharm Sci"},{"key":"9061_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF03033170","volume":"5","author":"C Barcia","year":"2003","unstructured":"Barcia C, Fern\u00e1ndez Barreiro A, Poza M, Herrero MT (2003) Parkinson\u2019s disease and inflammatory changes. Neurotox Res 5:411\u2013418","journal-title":"Neurotox Res"},{"key":"9061_CR5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/glia.20015","volume":"46","author":"C Barcia","year":"2004","unstructured":"Barcia C, S\u00e1nchez Bahillo A, Fern\u00e1ndez-Villalba E, Bautista V, Poza Y, Poza M, Fern\u00e1ndez-Barreiro A, Hirsch EC, Herrero MT (2004) Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1\u00a0year after MPTP exposure. Glia 46:402\u2013419","journal-title":"Glia"},{"key":"9061_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.1049","volume":"50","author":"HW Berendse","year":"2001","unstructured":"Berendse HW, Booij J, Francot CM, Bergmans PL, Hijman R, Stoof JC, Wolters EC (2001) Subclinical dopaminergic dysfunction in asymptomatic Parkinson\u2019s disease patients\u2019 relatives with a decreased sense of smell. Ann Neurol 50:34\u201341","journal-title":"Ann Neurol"},{"key":"9061_CR7","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1046\/j.1460-9568.2000.00180.x","volume":"12","author":"E Bezard","year":"2000","unstructured":"Bezard E, Jaber M, Gonon F, Boireau A, Bloch B, Gross CE (2000a) Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse. Eur J Neurosci 12:2892\u20132900","journal-title":"Eur J Neurosci"},{"key":"9061_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/1098-2396(20001201)38:3<363::AID-SYN16>3.0.CO;2-A","volume":"38","author":"E Bezard","year":"2000","unstructured":"Bezard E, Dovero S, Imbert C, Boraud T, Gross CE (2000b) Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Synapse 38:363\u2013368","journal-title":"Synapse"},{"key":"9061_CR9","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1046\/j.1471-4159.1995.64041669.x","volume":"64","author":"V Blanchard","year":"1995","unstructured":"Blanchard V, Chritin M, Vyas S, Savasta M, Feuerstein C, Agid Y, Javoy-Agid F, Raisman-Vozari R (1995) Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. J Neurochem 64:1669\u20131679","journal-title":"J Neurochem"},{"key":"9061_CR10","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.parkreldis.2008.04.015","volume":"2","author":"F Blandini","year":"2008","unstructured":"Blandini F, Armentero MT, Martignoni E (2008) The 6-hydroxydopamine model: news from the past. Parkinsonism Relat Disord 2:S124\u2013S129","journal-title":"Parkinsonism Relat Disord"},{"key":"9061_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"9061_CR12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1460-9568.2005.03944.x","volume":"21","author":"AR Carta","year":"2005","unstructured":"Carta AR, Tronci E, Pinna A, Morelli M (2005) Different responsiveness of striatonigral and striatopallidal neurons to l-DOPA after a subchronic intermittent l-DOPA treatment. Eur J Neurosci 21:1196\u20131204","journal-title":"Eur J Neurosci"},{"key":"9061_CR13","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J Neurosci 19:3248\u20133257","journal-title":"J Neurosci"},{"key":"9061_CR14","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1471-1931(00)00018-5","volume":"23","author":"TN Chase","year":"2000","unstructured":"Chase TN, Oh JD (2000) Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci 23:S86\u2013S91","journal-title":"Trends Neurosci"},{"key":"9061_CR15","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.parkreldis.2008.04.004","volume":"2","author":"MF Chesselet","year":"2008","unstructured":"Chesselet MF, Fleming S, Mortazavi F, Meurers B (2008) Strengths and limitations of genetic mouse models of Parkinson\u2019s disease. Parkinsonism Relat Disord 2:S84\u2013S87","journal-title":"Parkinsonism Relat Disord"},{"key":"9061_CR16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(97)00119-7","volume":"79","author":"RW Colburn","year":"1997","unstructured":"Colburn RW, DeLeo JA, Rickman AJ, Yeager MP, Kwon P, Hickey WF (1997) Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 79:163\u2013175","journal-title":"J Neuroimmunol"},{"key":"9061_CR17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0006-8993(00)03311-4","volume":"893","author":"C Dentresangle","year":"2001","unstructured":"Dentresangle C, Le Cavorsin M, Savasta M, Leviel V (2001) Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra. Brain Res 893:178\u2013185","journal-title":"Brain Res"},{"key":"9061_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.expneurol.2004.07.004","volume":"190","author":"AG Dervan","year":"2004","unstructured":"Dervan AG, Meshul CK, Beales M, McBean GJ, Moore C, Totterdell S, Snyder AK, Meredith GE (2004) Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson\u2019s disease. Exp Neurol 190:145\u2013156","journal-title":"Exp Neurol"},{"key":"9061_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2004.06.032","volume":"128","author":"DE Dluzen","year":"2004","unstructured":"Dluzen DE, McDermott JL, Anderson LI, Kucera J, Joyce JN, Osredkar T, Walro JM (2004) Age-related changes in nigrostriatal dopaminergic function are accentuated in \u00b1 brain-derived neurotrophic factor mice. Neuroscience 128:201\u2013208","journal-title":"Neuroscience"},{"key":"9061_CR20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0165-0270(91)90081-A","volume":"39","author":"R Drucker-Col\u00edn","year":"1991","unstructured":"Drucker-Col\u00edn R, Garc\u00eda-Hern\u00e1ndez F (1991) A new motor test sensitive to aging and dopaminergic function. J Neurosci Methods 39:153\u2013161","journal-title":"J Neurosci Methods"},{"key":"9061_CR21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0306-4522(99)00437-6","volume":"95","author":"JD Elsworth","year":"2000","unstructured":"Elsworth JD, Taylor JR, Sladek JR Jr, Collier TJ, Redmond DE Jr, Roth RH (2000) Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates 1\u00a0year after MPTP treatment. Neuroscience 95:399\u2013408","journal-title":"Neuroscience"},{"key":"9061_CR22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0306-4522(02)00778-9","volume":"116","author":"PO Fernagut","year":"2003","unstructured":"Fernagut PO, Chalon S, Diguet E, Guilloteau D, Tison F, Jaber M (2003) Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice. Neuroscience 116:1123\u20131130","journal-title":"Neuroscience"},{"key":"9061_CR23","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","volume":"24","author":"SM Fleming","year":"2004","unstructured":"Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF (2004) Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alphasynuclein. J Neurosci 24:9434\u20139440","journal-title":"J Neurosci"},{"key":"9061_CR24","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schl\u00fcter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, S\u00fcdhof TC (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102:3413\u20133418","journal-title":"Proc Natl Acad Sci USA"},{"key":"9061_CR25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0079-6123(08)61770-7","volume":"94","author":"LS Forno","year":"1992","unstructured":"Forno LS, DeLanney LE, Irwin I, Di Monte D, Langston JW (1992) Astrocytes and Parkinson\u2019s disease. Prog Brain Res 94:429\u2013436","journal-title":"Prog Brain Res"},{"key":"9061_CR26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1073858403255839","volume":"9","author":"CR Gerfen","year":"2003","unstructured":"Gerfen CR (2003) D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson\u2019s disease. Neuroscientist 9:455\u2013462","journal-title":"Neuroscientist"},{"key":"9061_CR27","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"CR Gerfen","year":"1990","unstructured":"Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429\u20131432","journal-title":"Science"},{"key":"9061_CR28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/mds.21413","volume":"22","author":"A Haehner","year":"2007","unstructured":"Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson\u2019s disease. Mov Disord 22:839\u2013842","journal-title":"Mov Disord"},{"key":"9061_CR29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","volume":"193","author":"A Hald","year":"2005","unstructured":"Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson\u2019s disease: is there a causal link? Exp Neurol 193:279\u2013290 (Review)","journal-title":"Exp Neurol"},{"key":"9061_CR30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","volume":"991","author":"EC Hirsch","year":"2003","unstructured":"Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP (2003) The role of glial reaction and inflammation in Parkinson\u2019s disease. Ann N Y Acad Sci 991:214\u2013228","journal-title":"Ann N Y Acad Sci"},{"key":"9061_CR31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","volume":"4","author":"V Jackson-Lewis","year":"1995","unstructured":"Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4:257\u2013269","journal-title":"Neurodegeneration"},{"key":"9061_CR32","first-page":"S16","volume":"2","author":"P Jenner","year":"2008","unstructured":"Jenner P (2008) Functional models of Parkinson\u2019s disease: a valuable tool in the development of novel therapies. Ann Neurol 2:S16\u2013S29","journal-title":"Ann Neurol"},{"key":"9061_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","volume":"39","author":"M Kohutnicka","year":"1998","unstructured":"Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Cz\u0142onkowski A, Cz\u0142onkowska A (1998) Microglial and astrocytic involvement in a murine model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology 39:167\u2013180","journal-title":"Immunopharmacology"},{"key":"9061_CR34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","volume":"156","author":"I Kurkowska-Jastrzebska","year":"1999","unstructured":"Kurkowska-Jastrzebska I, Wro\u0144ska A, Kohutnicka M, Cz\u0142onkowski A, Cz\u0142onkowska A (1999) The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse. Exp Neurol 156:50\u201361","journal-title":"Exp Neurol"},{"key":"9061_CR35","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"GT Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403\u20131409","journal-title":"Nat Med"},{"key":"9061_CR36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3940(87)90134-0","volume":"82","author":"JC Linder","year":"1987","unstructured":"Linder JC, Klemfuss H, Groves PM (1987) Acute ultrastructural and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Neurosci Lett 82:221\u2013226","journal-title":"Neurosci Lett"},{"key":"9061_CR37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF03033569","volume":"11","author":"AB Manning-Bog","year":"2007","unstructured":"Manning-Bog AB, Langston JW (2007) Model fusion, the next phase in developing animal models for Parkinson\u2019s disease. Neurotox Res 11:219\u2013240 Review","journal-title":"Neurotox Res"},{"key":"9061_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","volume":"73","author":"K Matsuura","year":"1997","unstructured":"Matsuura K, Kabuto H, Makino H, Ogawa N (1997) Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods 73:45\u201348","journal-title":"J Neurosci Methods"},{"key":"9061_CR39","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) Glial reactions in Parkinson\u2019s disease. Mov Disord 23:474\u2013483","journal-title":"Mov Disord"},{"key":"9061_CR40","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38:1285\u20131291","journal-title":"Neurology"},{"key":"9061_CR41","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/mds.21010","volume":"21","author":"GE Meredith","year":"2006","unstructured":"Meredith GE, Kang UJ (2006) Behavioral models of Parkinson\u2019s disease in rodents: a new look at an old problem. Mov Disord 21:1595\u20131606 Review","journal-title":"Mov Disord"},{"key":"9061_CR42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","volume":"22","author":"GE Meredith","year":"2002","unstructured":"Meredith GE, Totterdell S, Petroske E, Santa Cruz K, Callison RC Jr, Lau YS (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson\u2019s disease. Brain Res 22:156\u2013165","journal-title":"Brain Res"},{"key":"9061_CR43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/0-387-28066-9_32","volume-title":"The basal ganglia VIII","author":"GE Meredith","year":"2005","unstructured":"Meredith GE, Dervan AG, Totterdell S (2005) Activated microglia persist in the substantia nigra of a chronic MPTP mouse model of Parkinson\u2019s disease. In: Bolam JP, Ingham, Magill PJ (eds) The basal ganglia VIII. Springer Science, Singapore, pp 341\u2013347"},{"key":"9061_CR44","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","volume":"2","author":"GE Meredith","year":"2008","unstructured":"Meredith GE, Totterdell S, Potashkin JA, Surmeier DJ (2008) Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord 2:S112\u2013S115","journal-title":"Parkinsonism Relat Disord"},{"key":"9061_CR45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0361-9230(92)90035-V","volume":"28","author":"N Mitra","year":"1992","unstructured":"Mitra N, Mohanakumar KP, Ganguly DK (1992) Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Brain Res Bull 28:355\u2013364","journal-title":"Brain Res Bull"},{"key":"9061_CR46","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1006\/bbrc.1998.8986","volume":"248","author":"Y Mitsumoto","year":"1998","unstructured":"Mitsumoto Y, Watanabe A, Mori A, Koga N (1998) Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL\/6 mice. Biochem Biophys Res Commun 248:660\u2013663","journal-title":"Biochem Biophys Res Commun"},{"key":"9061_CR47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuroscience.2006.02.007","volume":"140","author":"L Novikova","year":"2006","unstructured":"Novikova L, Garris BL, Garris DR, Lau YS (2006) Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\/probenecid model of Parkinson\u2019s disease. Neuroscience 140:67\u201376","journal-title":"Neuroscience"},{"key":"9061_CR48","first-page":"435","volume":"50","author":"N Ogawa","year":"1985","unstructured":"Ogawa N, Hirose Y, Ohara S, Ono T, Watanabe Y (1985) A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol 50:435\u2013441","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"9061_CR49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000116351","volume":"1","author":"N Ogawa","year":"1987","unstructured":"Ogawa N, Mizukawa K, Hirose Y, Kajita S, Ohara S, Watanabe Y (1987) MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior. Eur Neurol 1:16\u201323","journal-title":"Eur Neurol"},{"key":"9061_CR50","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1002\/mds.21675","volume":"17","author":"CW Olanow","year":"2007","unstructured":"Olanow CW (2007) The pathogenesis of cell death in Parkinson\u2019s disease. Mov Disord 17:S335\u2013S342","journal-title":"Mov Disord"},{"key":"9061_CR51","first-page":"S101","volume":"2","author":"CW Olanow","year":"2008","unstructured":"Olanow CW, Kieburtz K, Schapira AH (2008) Why have we failed to achieve neuroprotection in Parkinson\u2019s disease? Ann Neurol 2:S101\u2013S110","journal-title":"Ann Neurol"},{"key":"9061_CR52","volume-title":"The mouse brain in stereotaxic coordinates","year":"2001","unstructured":"Paxinos G, Franklin KBJ (eds) (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego","edition":"2"},{"key":"9061_CR53","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1471-4159.2008.05268.x","volume":"105","author":"XA Perez","year":"2008","unstructured":"Perez XA, Parameswaran N, Huang LZ, O\u2019Leary KT, Quik M (2008) Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates. J Neurochem 105:1861\u20131872","journal-title":"J Neurochem"},{"key":"9061_CR54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","volume":"106","author":"E Petroske","year":"2001","unstructured":"Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS (2001) Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment. Neuroscience 106:589\u2013601","journal-title":"Neuroscience"},{"key":"9061_CR55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneumeth.2007.03.021","volume":"164","author":"LP Quinn","year":"2007","unstructured":"Quinn LP, Perren MJ, Brackenborough KT, Woodhams PL, Vidgeon-Hart M, Chapman H, Pangalos MN, Upton N, Virley DJ (2007) A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: pharmacological validation with R-(\u2212)-deprenyl. J Neurosci Methods 164:43\u201349","journal-title":"J Neurosci Methods"},{"key":"9061_CR56","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1523\/JNEUROSCI.14-05-02687.1994","volume":"14","author":"TE Robinson","year":"1994","unstructured":"Robinson TE, Mocsary Z, Camp DM, Whishaw IQ (1994) Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci 14:2687\u20132696","journal-title":"J Neurosci"},{"key":"9061_CR57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0969-9961(03)00108-6","volume":"14","author":"E Rousselet","year":"2003","unstructured":"Rousselet E, Joubert C, Callebert J, Parain K, Tremblay L, Orieux G, Launay JM, Cohen-Salmon C, Hirsch EC (2003) Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice. Neurobiol Dis 14:218\u2013228","journal-title":"Neurobiol Dis"},{"key":"9061_CR58","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1460-9568.2009.06657.x","volume":"29","author":"N Schintu","year":"2009","unstructured":"Schintu N, Frau L, Ibba M, Caboni P, Garau A, Carboni E, Carta AR (2009) PPAR-gamma mediated neuroprotection in a chronic mouse model of Parkinson\u2019s disease. Eur J Neurosci 29:954\u2013963","journal-title":"Eur J Neurosci"},{"key":"9061_CR59","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.parkreldis.2008.04.024","volume":"2","author":"B Schneider","year":"2008","unstructured":"Schneider B, Zufferey R, Aebischer P (2008) Viral vectors, animal models and new therapies for Parkinson\u2019s disease. Parkinsonism Relat Disord 2:S169\u2013S171","journal-title":"Parkinsonism Relat Disord"},{"key":"9061_CR60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","volume":"125","author":"M Sedelis","year":"2001","unstructured":"Sedelis M, Schwarting RK, Huston JP (2001) Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease. Behav Brain Res 125:109\u2013125","journal-title":"Behav Brain Res"},{"key":"9061_CR61","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbr.2006.11.001","volume":"177","author":"N Serradj","year":"2007","unstructured":"Serradj N, Jamon M (2007) Age-related changes in the motricity of the inbred mice strains 129\/sv, C57BL\/6j. Behav Brain Res 177:80\u201389","journal-title":"Behav Brain Res"},{"key":"9061_CR62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","volume":"134","author":"RJ Smeyne","year":"2005","unstructured":"Smeyne RJ, Jackson-Lewis V (2005) The MPTP model of Parkinson\u2019s disease. Brain Res Mol Brain Res 134:57\u201366","journal-title":"Brain Res Mol Brain Res"},{"key":"9061_CR63","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/1073858405278321","volume":"11","author":"MV Sofroniew","year":"2005","unstructured":"Sofroniew MV (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11:400\u2013407","journal-title":"Neuroscientist"},{"key":"9061_CR64","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.parkreldis.2008.04.008","volume":"2","author":"PK Sonsalla","year":"2008","unstructured":"Sonsalla PK, Zeevalk GD, German DC (2008) Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson\u2019s disease. Parkinsonism Relat Disord 2:S116\u2013S118","journal-title":"Parkinsonism Relat Disord"},{"key":"9061_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","volume":"208","author":"MG Tansey","year":"2007","unstructured":"Tansey MG, McCoy MK, Frank-Cannon TC (2007) Neuroinflammatory mechanisms in Parkinson\u2019s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol 208:1\u201325","journal-title":"Exp Neurol"},{"key":"9061_CR66","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763\u20131771","journal-title":"J Neurosci"},{"key":"9061_CR67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2006.02.002","volume":"200","author":"U Yazdani","year":"2006","unstructured":"Yazdani U, German DC, Liang CL, Manzino L, Sonsalla PK, Zeevalk GD (2006) Rat model of Parkinson\u2019s disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+). Exp Neurol 200:172\u2013183","journal-title":"Exp Neurol"},{"key":"9061_CR68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1427.023","volume":"147","author":"C Zhou","year":"2008","unstructured":"Zhou C, Huang Y, Przedborski S (2008) Oxidative stress in Parkinson\u2019s disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 147:93\u2013104","journal-title":"Ann N Y Acad Sci"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-009-9061-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-009-9061-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T13:31:12Z","timestamp":1559482272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-009-9061-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,27]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["9061"],"URL":"https:\/\/doi.org\/10.1007\/s12640-009-9061-x","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,27]]}}}